------------------------------
OMB APPROVAL
------------------------------
OMB Number
Expires:
Estimated average burden
hours per response ....... 0.5
------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )(1)
IntegraMed America, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
45810N 30 2
- --------------------------------------------------------------------------------
(CUSIP Number)
December 31, 1998
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-(c)
[_] Rule 13d-1(d)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(SC13G-07/98)
<PAGE>
CUSIP No. 45810N 30 2 13G Page of Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Gerardo Canet
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER: 576,624 shares (see Item 4(c)(i)).
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER: 92,423 shares
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
576,624 shares (see Item 4(a)).
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 11.39%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*: IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 45810N 30 2 13G Page of Pages
________________________________________________________________________________
Item 1(a). Name of Issuer: IntegraMed America, Inc.
________________________________________________________________________________
Item 1(b). Address of Issuer's Principal Executive Offices:
One Manhattanville Road
Purchase, NY 10577
________________________________________________________________________________
Item 2(a). Name of Person Filing:
Gerardo Canet
________________________________________________________________________________
Item 2(b). Address of Principal Business Office, or if None, Residence:
See Item 1(b).
________________________________________________________________________________
Item 2(c). Citizenship: USA
________________________________________________________________________________
Item 2(d). Title of Class of Securities: Common Stock
________________________________________________________________________________
Item 2(e). CUSIP Number: 45810N 30 2
________________________________________________________________________________
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box. [X]
<PAGE>
CUSIP No. 45810N 30 2 13G Page of Pages
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Mr. Canet benefically owns 576,624 shares of the Issuer's securities,
consisting of 31,250 shares of Issuer's Common Stock owned by Mr.
Canet, options exercisable within 60 days to purchase 61,173 shares
of Issuer's Common Stock and 484,201 shares of Issuer's Common Stock
held by certain individuals with respect to which Mr. Canet holds a
proxy to vote on the matters described in Item 4 (c)(i).
(b) Percent of class: 11.39%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
Mr. Canet has sole power to vote or to direct the vote: 576,624
shares, consisting of 31,250 shares of Issuer's Common Stock
owned by Mr. Canet, options exercisable within 60 days to
purchase 61,173 shares of Issuer's Common Stock and 484,201
shares of Issuer's Common Stock held by certain individuals with
respect to which Mr. Canet holds a proxy to vote for a two-year
period with respect: (a) to the election of Directors or any
amendment to Issuer's Certificate of Incorporation affecting
Directors and (b) any change in stock options for management and
Directors.
(ii) Shared power to vote or to direct the vote
(iii) Sole power to dispose or to direct the disposition of 92,423
shares of Common Stock,
(iv) Shared power to dispose or to direct the disposition of
________________________________________________________________________________
Item 5. Ownership of Five Percent or Less of a Class. Not applicable.
________________________________________________________________________________
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
484,201 shares, or 9.6%, represent shares for which Mr. Canet holds a
voting proxy on the matters described in Item 4(c)(i).
________________________________________________________________________________
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not applicable
________________________________________________________________________________
Item 8. Identification and Classification of Members of the Group.
Not applicable.
________________________________________________________________________________
Item 9. Notice of Dissolution of Group.
________________________________________________________________________________
Item 10. Certifications.
"By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having such purpose or effect."
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 16, 1999
----------------------------------------
(Date)
/s/Gerardo Canet
----------------------------------------
(Signature)
President and Chief Executive Officer
----------------------------------------
(Name/Title)
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
